Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial-Reference-Cited by-同舟云学术

Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

Published:2015-08 Issue:8 Volume:16 Page:937-948
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Tabernero Josep,Lenz Heinz-Josef,Siena Salvatore,Sobrero Alberto,Falcone Alfredo,Ychou Marc,Humblet Yves,Bouché Olivier,Mineur Laurent,Barone Carlo,Adenis Antoine,Yoshino Takayuki,Goldberg Richard M,Sargent Daniel J,Wagner Andrea,Laurent Dirk,Teufel Michael,Jeffers Michael,Grothey Axel,Van Cutsem Eric

Publisher

Elsevier BV

Subject

Oncology

Reference47 articles.

1. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer;Cunningham;N Engl J Med,2004

2. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study;Douillard;J Clin Oncol,2010

3. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

4. Cetuximab for the treatment of colorectal cancer;Jonker;N Engl J Med,2007

5. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial;Kabbinavar;J Clin Oncol,2005

Cited by 292 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stage-Specific Plasma Metabolomic Profiles in Colorectal Cancer;Journal of Clinical Medicine;2024-09-02

2. Comparing Baseline VAF in Circulating tumor DNA and Tumor Tissues Predicting Prognosis of Patients with Colorectal Cancer Liver Metastases After Curative Resection;Clinics and Research in Hepatology and Gastroenterology;2024-09

3. Exploratory Study Identifies Matrix Metalloproteinase-14 and -9 as Potential Biomarkers of Regorafenib Efficacy in Metastatic Colorectal Cancer;Cancers;2024-08-15

4. Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study;Cancer Chemotherapy and Pharmacology;2024-07-10

5. Dynamic ctDNA tracking stratifies individual relapse risk for early triple negative breast cancer patients receiving neoadjuvant chemotherapy;2024-07-10